A Phase I Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants

Conditions: Cytomegalovirus Infections Interventions: Biological: SPYVAC01 Sponsors: SpyBiotech Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials